Until more is known, use cautiously
For the first time, we saw that more than 50% of people achieved an [hemoglobin] A 1c less than 5.7. Recent studies into the effects of GLP-1s on cardiovascular events have also been promising, with a 3 In the past, these differences would be seen after around 12 years compared with more recent studies
regulator to prevent compounders from manufacturing copycat versions of its juggernaut diabetes and obesity treatments Ozempic and Wegovy, claiming the drugs are too complex to replicate safely
doi: 10.1084/jem.20210518 61 HandaPThomasSMorgan-StevensonVMalikenBDGochanourEBoukharSet al
We now know after more than 15 years of GLP-1 therapy that we can see cardioprotection, reduction in blood pressure, and we know we can see a reduction in body weight, Davies said
Conte C, Hall KD, Klein S